NO20002483L - Nye 19-norsteroider substituert i posisjon 11B, fremstillingsfremgangsmÕte og intermediater, anvendelse som medisiner og farmasøytiske preparater som inneholder dem - Google Patents
Nye 19-norsteroider substituert i posisjon 11B, fremstillingsfremgangsmÕte og intermediater, anvendelse som medisiner og farmasøytiske preparater som inneholder demInfo
- Publication number
- NO20002483L NO20002483L NO20002483A NO20002483A NO20002483L NO 20002483 L NO20002483 L NO 20002483L NO 20002483 A NO20002483 A NO 20002483A NO 20002483 A NO20002483 A NO 20002483A NO 20002483 L NO20002483 L NO 20002483L
- Authority
- NO
- Norway
- Prior art keywords
- norsteroids
- medicines
- heading
- intermediates
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
- C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Veterinary Medicine (AREA)
- Rheumatology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9714357A FR2771096B1 (fr) | 1997-11-17 | 1997-11-17 | Nouveaux 19-nor steroides, substitues en position 11beta, procede et intermediaires de preparation, application comme medicaments et compositions pharmaceutiques les renfermant |
| PCT/FR1998/002437 WO1999025725A1 (fr) | 1997-11-17 | 1998-11-16 | NOUVEAUX 19-NOR STEROÏDES SUBSTITUES EN POSITION 11β, PROCEDE ET INTERMEDIAIRES DE PREPARATION, APPLICATION COMME MEDICAMENTS ET COMPOSITIONS PHARMACEUTIQUES LES RENFERMANT |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20002483D0 NO20002483D0 (no) | 2000-05-12 |
| NO20002483L true NO20002483L (no) | 2000-07-17 |
Family
ID=9513422
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20002483A NO20002483L (no) | 1997-11-17 | 2000-05-12 | Nye 19-norsteroider substituert i posisjon 11B, fremstillingsfremgangsmÕte og intermediater, anvendelse som medisiner og farmasøytiske preparater som inneholder dem |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US6479476B1 (sk) |
| EP (1) | EP1032584B1 (sk) |
| JP (1) | JP4476480B2 (sk) |
| KR (1) | KR20010032127A (sk) |
| CN (1) | CN1286694A (sk) |
| AR (1) | AR016012A1 (sk) |
| AT (1) | ATE232542T1 (sk) |
| AU (1) | AU754846B2 (sk) |
| BR (1) | BR9814201A (sk) |
| CA (1) | CA2309242A1 (sk) |
| CZ (1) | CZ20001799A3 (sk) |
| DE (1) | DE69811393T2 (sk) |
| EA (1) | EA003133B1 (sk) |
| ES (1) | ES2192341T3 (sk) |
| FR (1) | FR2771096B1 (sk) |
| HR (1) | HRP20000315A2 (sk) |
| HU (1) | HUP0100210A3 (sk) |
| ID (1) | ID24236A (sk) |
| IL (1) | IL136148A0 (sk) |
| NO (1) | NO20002483L (sk) |
| PL (1) | PL340381A1 (sk) |
| SK (1) | SK7052000A3 (sk) |
| TR (1) | TR200001405T2 (sk) |
| WO (1) | WO1999025725A1 (sk) |
| ZA (1) | ZA9810358B (sk) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2757519B1 (fr) * | 1996-12-23 | 1999-06-11 | Hoechst Marion Roussel Inc | Steroides substitues en position 11, leur procede de preparation, leur application comme medicament et les compositions pharmaceutiques les renfermant |
| FR2780060B1 (fr) * | 1998-06-23 | 2000-08-04 | Hoechst Marion Roussel Inc | Nouveaux 19-nor steroides 17-halogenes, procede et intermediaires de preparation, application comme medicaments et compositions pharmaceutiques les renfermant |
| DE19929715A1 (de) * | 1999-06-24 | 2000-12-28 | Schering Ag | 11ß-langkettig-substituierte Estratriene, Verfahren zur Herstellung , pharmazeutische Präparate, die diese 11ß-langkettig-substituierten Estratriene enthalten, sowie deren Verwendung zur Herstellung von Arzneimitteln |
| FR2826004B1 (fr) * | 2001-06-13 | 2008-03-28 | Aventis Pharma Sa | Procede de preparation de derives estrogenes |
| FR2854403B1 (fr) * | 2003-04-29 | 2008-07-11 | Aventis Pharma Sa | Nouveau procede et intermediaires de preparation de composes 19-nor-steroides 17-halogenes |
| FR2854402B1 (fr) * | 2003-04-29 | 2008-07-04 | Aventis Pharma Sa | Nouveau procede et intermediaires de preparation de composes 19-nor-steroides |
| EP3224230B1 (en) * | 2014-11-26 | 2020-01-08 | The Regents of The University of California | Estrogen receptor modulators |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4978657A (en) * | 1981-01-09 | 1990-12-18 | Roussel Uclaf | Novel 11β-substituted-19-nor-steroids |
| FR2640977A2 (en) * | 1982-06-11 | 1990-06-29 | Roussel Uclaf | New position-11 substituted 19-norsteroids and their application as medicinal products. |
| FR2643638B1 (fr) * | 1989-02-24 | 1991-06-14 | Roussel Uclaf | Nouveaux 19-nor steroides ayant en position 11beta une chaine carbonee comportant une fonction amide ou carbamate, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les contenant |
-
1997
- 1997-11-17 FR FR9714357A patent/FR2771096B1/fr not_active Expired - Fee Related
-
1998
- 1998-11-12 ZA ZA9810358A patent/ZA9810358B/xx unknown
- 1998-11-16 BR BR9814201-1A patent/BR9814201A/pt not_active IP Right Cessation
- 1998-11-16 CZ CZ20001799A patent/CZ20001799A3/cs unknown
- 1998-11-16 TR TR2000/01405T patent/TR200001405T2/xx unknown
- 1998-11-16 AU AU12426/99A patent/AU754846B2/en not_active Ceased
- 1998-11-16 SK SK705-2000A patent/SK7052000A3/sk unknown
- 1998-11-16 ID IDW20000928A patent/ID24236A/id unknown
- 1998-11-16 AT AT98955663T patent/ATE232542T1/de not_active IP Right Cessation
- 1998-11-16 HU HU0100210A patent/HUP0100210A3/hu unknown
- 1998-11-16 DE DE69811393T patent/DE69811393T2/de not_active Expired - Lifetime
- 1998-11-16 WO PCT/FR1998/002437 patent/WO1999025725A1/fr not_active Application Discontinuation
- 1998-11-16 IL IL13614898A patent/IL136148A0/xx unknown
- 1998-11-16 US US09/554,783 patent/US6479476B1/en not_active Expired - Lifetime
- 1998-11-16 CA CA002309242A patent/CA2309242A1/fr not_active Abandoned
- 1998-11-16 EA EA200000530A patent/EA003133B1/ru not_active IP Right Cessation
- 1998-11-16 JP JP2000521105A patent/JP4476480B2/ja not_active Expired - Fee Related
- 1998-11-16 KR KR1020007005314A patent/KR20010032127A/ko not_active Application Discontinuation
- 1998-11-16 CN CN98813160A patent/CN1286694A/zh active Pending
- 1998-11-16 EP EP98955663A patent/EP1032584B1/fr not_active Expired - Lifetime
- 1998-11-16 PL PL98340381A patent/PL340381A1/xx unknown
- 1998-11-16 ES ES98955663T patent/ES2192341T3/es not_active Expired - Lifetime
- 1998-11-17 AR ARP980105822A patent/AR016012A1/es unknown
-
2000
- 2000-05-12 NO NO20002483A patent/NO20002483L/no not_active Application Discontinuation
- 2000-05-17 HR HR20000315A patent/HRP20000315A2/hr not_active Application Discontinuation
-
2002
- 2002-04-10 US US10/119,903 patent/US6693090B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999025725A1 (fr) | 1999-05-27 |
| ZA9810358B (en) | 1999-11-12 |
| HRP20000315A2 (en) | 2000-10-31 |
| EA200000530A1 (ru) | 2000-10-30 |
| FR2771096A1 (fr) | 1999-05-21 |
| NO20002483D0 (no) | 2000-05-12 |
| AU1242699A (en) | 1999-06-07 |
| DE69811393D1 (de) | 2003-03-20 |
| EA003133B1 (ru) | 2003-02-27 |
| CZ20001799A3 (cs) | 2001-11-14 |
| ES2192341T3 (es) | 2003-10-01 |
| FR2771096B1 (fr) | 2000-08-11 |
| KR20010032127A (ko) | 2001-04-16 |
| TR200001405T2 (tr) | 2001-05-21 |
| HUP0100210A3 (en) | 2001-12-28 |
| ATE232542T1 (de) | 2003-02-15 |
| AR016012A1 (es) | 2001-05-30 |
| BR9814201A (pt) | 2000-09-26 |
| ID24236A (id) | 2000-07-13 |
| EP1032584A1 (fr) | 2000-09-06 |
| US6693090B2 (en) | 2004-02-17 |
| JP4476480B2 (ja) | 2010-06-09 |
| DE69811393T2 (de) | 2003-08-28 |
| AU754846B2 (en) | 2002-11-28 |
| IL136148A0 (en) | 2001-05-20 |
| PL340381A1 (en) | 2001-01-29 |
| US6479476B1 (en) | 2002-11-12 |
| CA2309242A1 (fr) | 1999-05-27 |
| JP2001523687A (ja) | 2001-11-27 |
| CN1286694A (zh) | 2001-03-07 |
| EP1032584B1 (fr) | 2003-02-12 |
| US20030073675A1 (en) | 2003-04-17 |
| HUP0100210A1 (hu) | 2001-08-28 |
| SK7052000A3 (en) | 2000-12-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO308298B1 (no) | Substituerte kinazolinderivater, anvendelse derav og farmasøytiske preparater inneholdende dem | |
| NO982590D0 (no) | Metalloproteinase-inhibitorer, farmas°ytiske blandinger inneholdende dem og deres farmas°ytiske anvendelser, og fremgangsmÕter og mellomprodukter anvendelige for deres fremstilling | |
| FI973278A0 (fi) | Uudet farnesyylitransferaasin inhibiittorit, niiden valmistus ja niitä sisältävät farmaseuttiset valmisteet | |
| IS1950B (is) | Arýlsúlfonýlamínó hýdroxamsýruafleiður, notkun þeirra, ásamt lyfjablöndum | |
| IS5130A (is) | Arýlsúlfonýlamínó hýdroxamsýruafleiður, notkun þeirra, ásamt lyfjablöndum | |
| NO20003314L (no) | Nye tetravcykliske analoger av camptotheciner, deres fremstillingsprosesser, anvendelse av dem som medikamenter og farmasøytiske preparater inneholdende dem | |
| NO871111L (no) | Tertiaere hydroksyalkylxantiner, fremgangsmaate til deres fremstilling, legemidler som inneholder dem og deres anvendelse. | |
| NO982580D0 (no) | Nye taxoider, deres fremstilling samt farmas°ystiske preparater inneholdende taxoidene | |
| NO307925B1 (no) | Bicykliske aromatiske forbindelser, anvendelse derav, og farmasøytiske og kosmetiske preparater | |
| NO20051645L (no) | Nye aminoindozolderivater som medisin og farmakologiske preparater inneholdende disse | |
| NO894228D0 (no) | Tienopyridiner, fremstilling, mellomprodukter og farmasoeytiske preparater. | |
| NL194239B (nl) | Dialkoxyfosfinolmethylbenzamideverbindingen en farmaceutische preparaten, die deze bevatten. | |
| NO952677D0 (no) | Nye dihydropyrrolopyridinon- og oksazolopyridinonforbindelser, deres fremstilling og farmasöytiske preparater | |
| NO20010031D0 (no) | Derivater av 2-aminopyridiner, anvendelse av dem som medikamenter og farmasöytiske preparater inneholdende dem | |
| NO984309D0 (no) | Nye imidazolidinderivater, deres fremstilling, deres anvendelse og farmas°ytiske preparater inneholdende disse | |
| NO965102D0 (no) | Bicykliske aromatiske forbindelser, anvendelser derav, og farmasöytiske og kosmetiske preparater | |
| DK1015421T3 (da) | Nye phenylamidinderivater, fremgangsmåder til deres fremstilling og deres anvendelse som lægemidler | |
| NO994659D0 (no) | Nye pyridinderivater og farmasöytiske preparater inneholdende slike | |
| NO305286B1 (no) | Kinoksalinforbindelser, farmas°ytiske preparater som omfatter dem, og anvendelse derav for fremstilling av medikamenter | |
| NO20002483L (no) | Nye 19-norsteroider substituert i posisjon 11B, fremstillingsfremgangsmÕte og intermediater, anvendelse som medisiner og farmasøytiske preparater som inneholder dem | |
| NO20003661L (no) | Nye pentasakkarider, fremgangsmÕter for deres fremstilling og farmasøytiske preparater inneholdende de samme | |
| NO992998L (no) | Nye analoger av camptotecin, anvendelse som medikamenter og farmasöytiske blandinger som inneholder disse | |
| NO20003290L (no) | N-fenylamid- og N-pyridylamidderivater, fremgangsmÕte for fremstilling av dem, og farmasøytiske preparater som inneholder dem | |
| DK409786D0 (da) | 6-phenoxymethyl-4-hydroxytetrahydropyran-2-oner, fremgangsmaade til fremstilling deraf, deres anvendelse som laegemidler, pharmaceutiske praeparater og mellemprodukter | |
| NO304378B1 (no) | Nye imidazopyridinderivater som er angiotensin II-antagonister, farmas°ytiske preparater som inneholder dem, og deres anvendelse til fremstilling av medikamenter |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |